serine has been researched along with Cardiomyopathy, Hypertrophic in 6 studies
Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.
Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, the contribution of tyrosine phosphorylation (pTyr) to the pathogenesis of cardiac hypertrophy remains unclear." | 4.12 | Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy. ( Ayati, M; Bermea, KC; Everett, AD; Foster, DB; Fu, Z; Gabrielson, K; Heravi, A; Kim, HB; Medina, A; Murphy, AM; Na, CH; Paolocci, N; Ramirez-Correa, GA; Xu, M; Yang, X; Zhang, X, 2022) |
| "Cardiac hypertrophy is characterized by transcriptional reprogramming of fetal gene expression, and histone deacetylases (HDACs) are tightly linked to the regulation of those genes." | 1.37 | Casein kinase-2α1 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart. ( Cho, YK; Choe, N; Eom, GH; Joung, H; Kee, HJ; Kim, HS; Kim, Y; Ko, JH; Kook, H; Nam, KI; Shin, S, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, M | 3 |
| Bermea, KC | 3 |
| Ayati, M | 3 |
| Kim, HB | 3 |
| Yang, X | 3 |
| Medina, A | 3 |
| Fu, Z | 3 |
| Heravi, A | 3 |
| Zhang, X | 3 |
| Na, CH | 3 |
| Everett, AD | 3 |
| Gabrielson, K | 3 |
| Foster, DB | 3 |
| Paolocci, N | 3 |
| Murphy, AM | 3 |
| Ramirez-Correa, GA | 3 |
| Doh, CY | 1 |
| Li, J | 1 |
| Mamidi, R | 1 |
| Stelzer, JE | 1 |
| Cheng, Y | 1 |
| Lindert, S | 1 |
| Oxenford, L | 1 |
| Tu, AY | 1 |
| McCulloch, AD | 1 |
| Regnier, M | 1 |
| Eom, GH | 1 |
| Cho, YK | 1 |
| Ko, JH | 1 |
| Shin, S | 1 |
| Choe, N | 1 |
| Kim, Y | 1 |
| Joung, H | 1 |
| Kim, HS | 1 |
| Nam, KI | 1 |
| Kee, HJ | 1 |
| Kook, H | 1 |
| Laforêt, P | 1 |
| Richard, P | 1 |
| Said, MA | 1 |
| Romero, NB | 1 |
| Lacene, E | 1 |
| Leroy, JP | 1 |
| Baussan, C | 1 |
| Hogrel, JY | 1 |
| Lavergne, T | 1 |
| Wahbi, K | 1 |
| Hainque, B | 1 |
| Duboc, D | 1 |
| Quane, KA | 1 |
| Keating, KE | 1 |
| Healy, JM | 1 |
| Manning, BM | 1 |
| Krivosic-Horber, R | 1 |
| Krivosic, I | 1 |
| Monnier, N | 1 |
| Lunardi, J | 1 |
| McCarthy, TV | 1 |
6 other studies available for serine and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy.
Topics: Animals; Cardiomegaly; Cardiomyopathy, Hypertrophic; Mice; Phosphorylation; Proteome; Serine; Threon | 2022 |
Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy.
Topics: Animals; Cardiomegaly; Cardiomyopathy, Hypertrophic; Mice; Phosphorylation; Proteome; Serine; Threon | 2022 |
Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy.
Topics: Animals; Cardiomegaly; Cardiomyopathy, Hypertrophic; Mice; Phosphorylation; Proteome; Serine; Threon | 2022 |
Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy.
Topics: Animals; Cardiomegaly; Cardiomyopathy, Hypertrophic; Mice; Phosphorylation; Proteome; Serine; Threon | 2022 |
Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy.
Topics: Animals; Cardiomegaly; Cardiomyopathy, Hypertrophic; Mice; Phosphorylation; Proteome; Serine; Threon | 2022 |
Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy.
Topics: Animals; Cardiomegaly; Cardiomyopathy, Hypertrophic; Mice; Phosphorylation; Proteome; Serine; Threon | 2022 |
Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy.
Topics: Animals; Cardiomegaly; Cardiomyopathy, Hypertrophic; Mice; Phosphorylation; Proteome; Serine; Threon | 2022 |
Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy.
Topics: Animals; Cardiomegaly; Cardiomyopathy, Hypertrophic; Mice; Phosphorylation; Proteome; Serine; Threon | 2022 |
Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy.
Topics: Animals; Cardiomegaly; Cardiomyopathy, Hypertrophic; Mice; Phosphorylation; Proteome; Serine; Threon | 2022 |
The HCM-causing Y235S cMyBPC mutation accelerates contractile function by altering C1 domain structure.
Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Cardiomyopathy, Hypertrophic; Carrier Protein | 2019 |
Effects of Cardiac Troponin I Mutation P83S on Contractile Properties and the Modulation by PKA-Mediated Phosphorylation.
Topics: Amino Acid Substitution; Animals; Calcium; Cardiomyopathy, Hypertrophic; Cyclic AMP-Dependent Protei | 2016 |
Casein kinase-2α1 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart.
Topics: Alanine; Animals; Cardiomegaly; Cardiomyopathy, Hypertrophic; Casein Kinase II; Enzyme Activation; H | 2011 |
A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosis.
Topics: Adult; AMP-Activated Protein Kinases; Cardiomyopathy, Hypertrophic; DNA Mutational Analysis; Exercis | 2006 |
Mutation screening of the RYR1 gene in malignant hyperthermia: detection of a novel Tyr to Ser mutation in a pedigree with associated central cores.
Topics: Amino Acid Sequence; Base Sequence; Calcium Channels; Cardiomyopathy, Hypertrophic; Chromosomes, Hum | 1994 |